Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Himfill-XT is a brand name marketed by Varmed Pharma in India for a range of hematinic products used to treat or prevent iron deficiency anemia and associated nutritional deficiencies. The tablet formulation of Himfill-XT is a fixed-dose combination containing ferrous ascorbate (iron), folic acid (vitamin B9), and zinc sulfate. Ferrous ascorbate serves as a highly absorbable source of iron to support hemoglobin synthesis, folic acid is essential for red blood cell production and DNA synthesis, and zinc acts as a cofactor for numerous enzymes involved in cellular metabolism and immune function. Additionally, Varmed Pharma markets a syrup formulation under the same brand name containing ferric ammonium citrate, cyanocobalamin (vitamin B12), and folic acid, as well as an injection formulation containing iron sucrose.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Himfill-XT.